Advanced Search

Technical Analysis for IVA - Inventiva S.A.

Grade Last Price % Change Price Change
F 13.22 0.69% 0.09
IVA closed up 0.69 percent on Thursday, April 22, 2021, on 16 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical IVA trend table...
Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.69%
Narrow Range Bar Range Contraction 0.69%
Outside Day Range Expansion 0.69%
Oversold Stochastic Weakness 0.69%
Narrow Range Bar Range Contraction -0.38%
NR7 Range Contraction -0.38%
Inside Day Range Contraction -0.38%
Older End-of-Day Signals for IVA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 4 days ago
Outside Day 4 days ago
Up 2% 4 days ago
Up 1% 4 days ago
Fell Below Previous Day's Low 4 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Alcohol Genetics Gene Expression Steatohepatitis Hepatitis Non Alcoholic Fatty Liver Disease Transcription Fibrosis Related Disease Related Diseases Transcription Factors DNA Small Molecule Therapies Transcription Factor Epigenetics Hepatitis A Receptor

Is IVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 19 Appointment of Martine Zimmermann as Independent Director to Inventiva’s Board of Directors
Apr 19 Results of the votes of the Combined Shareholders’ Meeting of April 16, 2021
Mar 25 Inventiva's Combined Shareholders Meeting of April 16, 2021 - Availability of the preparatory documents and methods for participating and voting
Mar 25 Statement of total voting rights and shares forming the company’s share capital on March 10th, 2021
Mar 15 Inventiva announces filing of its 2020 Universal Registration Document and 2020 Annual Report on Form 20-F
Mar 6 Inventiva S.A. (IVEVF) CEO Frédéric Cren on Q4 2020 Results - Earnings Call Transcript
Mar 5 Inventiva (IVEVF) Investor Presentation - Slideshow
Mar 4 2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States
Mar 4 Earnings Scheduled For March 4, 2021
Feb 25 Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvemen
See more IVA news...

Indicators

Indicator Value
52 Week High 19.14
52 Week Low 9.01
Average Volume 32,992
200-Day Moving Average 0.00
50-Day Moving Average 14.47
20-Day Moving Average 14.11
10-Day Moving Average 13.63
Average True Range 0.63
ADX 24.85
+DI 25.76
-DI 17.80
Chandelier Exit (Long, 3 ATRs ) 13.62
Chandelier Exit (Short, 3 ATRs ) 14.23
Upper Bollinger Band 15.38
Lower Bollinger Band 12.83
Percent B (%b) 0.15
BandWidth 18.05
MACD Line -0.30
MACD Signal Line -0.19
MACD Histogram -0.1073
Fundamentals Value
Market Cap 507.37 Million
Num Shares 38.4 Million
EPS -1.32
Price-to-Earnings (P/E) Ratio -10.05
Price-to-Sales 53.25
Price-to-Book 10.42
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.63
Resistance 3 (R3) 13.67 13.58 13.56
Resistance 2 (R2) 13.58 13.48 13.56 13.53
Resistance 1 (R1) 13.40 13.41 13.36 13.36 13.51
Pivot Point 13.31 13.31 13.29 13.29 13.31
Support 1 (S1) 13.13 13.21 13.09 13.09 12.93
Support 2 (S2) 13.04 13.14 13.02 12.91
Support 3 (S3) 12.86 13.04 12.88
Support 4 (S4) 12.82